Previous Article | Next Article ![]()
Mol. Cell. Biol., 02 1995, 925-931, Vol 15, No. 2
LF Fleischman, L Holtzclaw, JT Russell, G Mavrothalassitis and RJ Fisher
The ets-1 protein has been primarily studied as a sequence-specific
transcriptional regulator that is predominately expressed in lymphoid
cells. In this report, we show that ets-1 is also expressed in astrocytes
and astrocytoma cells and is regulated during both signal transduction and
differentiation. Both isoforms of ets-1, p51 and p42, were found in
astrocytes and astrocytoma cells, but whereas expression of p51 was strong,
p42, the alternate splice product previously shown to lack the
phosphorylation domain, was difficult to detect and was present at a level
10- to 40-fold lower than that of p51. This differed by roughly an order of
magnitude from the ratio generally observable in T cells and thymocytes. In
two astrocytoma lines of human origin, CCF and 1321N1, ets-1
phosphorylation was stimulated by bradykinin and carbachol, respectively.
Glutamate, norepinephrine, and bradykinin elicited phosphorylation of p51
in cultures of primary rat type 1 astrocytes. ets-1 phosphorylation was
dramatically blocked by KT5926, an inhibitor of myosin light-chain kinase,
suggesting that this kinase may be involved in phosphorylation of ets-1 in
vivo. Investigations of retinoic acid-induced differentiation in P19 cells
provided further support for a strong correlation of ets-1 with the pathway
for astrocyte differentiation.
Copyright © 1995, American Society for Microbiology
ets-1 in astrocytes: expression and transmitter-evoked phosphorylation
Laboratory of Molecular Oncology, National Cancer Institute, Frederick, Maryland.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|